[go: up one dir, main page]

SE0400346D0 - Steroids for cancer treatment - Google Patents

Steroids for cancer treatment

Info

Publication number
SE0400346D0
SE0400346D0 SE0400346A SE0400346A SE0400346D0 SE 0400346 D0 SE0400346 D0 SE 0400346D0 SE 0400346 A SE0400346 A SE 0400346A SE 0400346 A SE0400346 A SE 0400346A SE 0400346 D0 SE0400346 D0 SE 0400346D0
Authority
SE
Sweden
Prior art keywords
compounds
relates
steroids
cancer treatment
treatment
Prior art date
Application number
SE0400346A
Other languages
English (en)
Other versions
SE527131C2 (sv
SE0400346L (sv
Inventor
Lars Pettersson
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Priority to SE0400346A priority Critical patent/SE527131C2/sv
Publication of SE0400346D0 publication Critical patent/SE0400346D0/sv
Priority to US10/587,561 priority patent/US20070142345A1/en
Priority to EP05711049A priority patent/EP1716166A2/en
Priority to AU2005212210A priority patent/AU2005212210A1/en
Priority to CNA2005800047257A priority patent/CN101076538A/zh
Priority to PCT/SE2005/000188 priority patent/WO2005077968A2/en
Priority to CA002552843A priority patent/CA2552843A1/en
Priority to JP2006553092A priority patent/JP2007522211A/ja
Publication of SE0400346L publication Critical patent/SE0400346L/sv
Publication of SE527131C2 publication Critical patent/SE527131C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0400346A 2004-02-13 2004-02-13 Steroider för cancerbehandling SE527131C2 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0400346A SE527131C2 (sv) 2004-02-13 2004-02-13 Steroider för cancerbehandling
US10/587,561 US20070142345A1 (en) 2004-02-13 2005-02-11 Steroids for cancer treatment
EP05711049A EP1716166A2 (en) 2004-02-13 2005-02-11 17-methylene- or 17-spiro-cyclopropane 7-substituted estra-1,3,5(10)-triene derivatives with anti-estrogenic activity
AU2005212210A AU2005212210A1 (en) 2004-02-13 2005-02-11 Steroids for cancer treatment
CNA2005800047257A CN101076538A (zh) 2004-02-13 2005-02-11 用于癌症治疗的类固醇
PCT/SE2005/000188 WO2005077968A2 (en) 2004-02-13 2005-02-11 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
CA002552843A CA2552843A1 (en) 2004-02-13 2005-02-11 Steroids for cancer treatment
JP2006553092A JP2007522211A (ja) 2004-02-13 2005-02-11 癌治療用ステロイド

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400346A SE527131C2 (sv) 2004-02-13 2004-02-13 Steroider för cancerbehandling

Publications (3)

Publication Number Publication Date
SE0400346D0 true SE0400346D0 (sv) 2004-02-13
SE0400346L SE0400346L (sv) 2005-08-14
SE527131C2 SE527131C2 (sv) 2005-12-27

Family

ID=31974231

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400346A SE527131C2 (sv) 2004-02-13 2004-02-13 Steroider för cancerbehandling

Country Status (8)

Country Link
US (1) US20070142345A1 (sv)
EP (1) EP1716166A2 (sv)
JP (1) JP2007522211A (sv)
CN (1) CN101076538A (sv)
AU (1) AU2005212210A1 (sv)
CA (1) CA2552843A1 (sv)
SE (1) SE527131C2 (sv)
WO (1) WO2005077968A2 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20071479A1 (it) * 2007-07-23 2009-01-24 Ind Chimica Srl Processo per la preparazione di 7alfa-[9-(4,4,5,5,5-pentafluortiopentil)nonil]estra-1,3,5(10)-trien-3,17beta-diolo
WO2009039700A1 (en) * 2007-09-24 2009-04-02 Xi'an Libang Pharmaceutical Co., Ltd. Process for the manufacture of 7-alpha-[9-(4,4,5,5,5-penta fluoropentvlsulphinvl) nonvllestra-l,3,5-(10)- triene-3,17-beta-diol
US8669243B2 (en) * 2007-10-30 2014-03-11 The Wistar Institute Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer
WO2009058945A1 (en) * 2007-10-30 2009-05-07 The Wistar Institute Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer
JP5803136B2 (ja) * 2011-02-23 2015-11-04 東ソー株式会社 アミド含有スルフィド化合物、並びにその製造方法及び用途
JP5776200B2 (ja) * 2011-02-09 2015-09-09 住友化学株式会社 チオカルボン酸ｓ−（フルオロアルキル）エステルの製造方法
US9315540B2 (en) 2012-10-22 2016-04-19 Intas Pharmaceuticals Ltd. Process for the preparation of fulvestrant
WO2015145417A1 (en) 2014-03-28 2015-10-01 Ilan Ziv Compounds and methods for trans-membrane delivery of molecules
US9889202B2 (en) 2014-03-28 2018-02-13 Aposense Ltd. Compounds and methods for trans-membrane delivery of molecules
US9993563B2 (en) 2014-03-28 2018-06-12 Aposense Ltd. Compounds and methods for trans-membrane delivery of molecules
US11318206B2 (en) 2014-03-28 2022-05-03 Aposense Ltd Compounds and methods for trans-membrane delivery of molecules
CN103965280B (zh) * 2014-05-21 2016-04-20 天津孚音生物科技发展有限公司 一种氟维司群中间体的制备方法
US10112962B2 (en) * 2014-07-02 2018-10-30 Xavier University Boron-based prodrug strategy for increased bioavailability and lower-dosage requirements for drug molecules containing at least one phenol (or aromatic hydroxyl) group
CN109415388A (zh) * 2016-05-06 2019-03-01 路易斯安那泽维尔大学 选择性雌激素受体下调剂(serds)
EP3565603B1 (en) 2017-01-09 2022-12-07 Aposense Ltd. Compounds and methods for trans-membrane delivery of molecules
JP2021509406A (ja) 2018-01-01 2021-03-25 アポセンス リミテッドＡｐｏｓｅｎｓｅ Ｌｔｄ． 分子の膜貫通送達のための化合物および方法
CN111116428B (zh) * 2018-11-01 2023-09-15 江苏豪森药业集团有限公司 制备氟维司群的方法和中间体
CA3241257A1 (en) * 2021-12-06 2023-06-15 Kashiv Biosciences, Llc Compounds for the treatment of cancer
CN114805461B (zh) * 2022-04-14 2023-04-21 东南大学 一种苯环苄位c-h键氧化成酮的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9502921D0 (sv) * 1995-08-23 1995-08-23 Astra Ab New compounds

Also Published As

Publication number Publication date
CN101076538A (zh) 2007-11-21
SE527131C2 (sv) 2005-12-27
US20070142345A1 (en) 2007-06-21
JP2007522211A (ja) 2007-08-09
WO2005077968A8 (en) 2006-11-16
CA2552843A1 (en) 2005-08-25
AU2005212210A1 (en) 2005-08-25
WO2005077968A2 (en) 2005-08-25
WO2005077968A3 (en) 2006-08-31
EP1716166A2 (en) 2006-11-02
WO2005077968B1 (en) 2007-01-04
SE0400346L (sv) 2005-08-14

Similar Documents

Publication Publication Date Title
SE0400346D0 (sv) Steroids for cancer treatment
NO2017019I1 (no) Diarylhydantoinforbindelse, farmasøytisk sammensetning og anvendelse derav
CL2008001839A1 (es) Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
BRPI0607523A2 (pt) compostos esteróides de heteroarila c-17, composições farmacêuticas compreendendo os mesmos e uso dos referidos compostos na preparação de medicamentos
CY1107906T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου
AR057060A1 (es) Composiciones de tanaproget que contienen etinil estradiol
WO2006015259A3 (en) Compounds and compositions as modulators of steroid hormone nuclear receptors
ATE449097T1 (de) Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
CL2007002578A1 (es) Compuestos derivados de n-(1-ftalazin-1-il-piperidin-4-il)-amidas; composicion farmaceutica; y uso para el tratamiento y prevencion de trastornos de la fertilidad, osteoporosis y cancer.
GEP20115213B (en) Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
EA201000436A1 (ru) Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
WO2008034142A3 (en) Synthesis, methods of using, and compositions of cycloalkylmethylamines
EP2425874A3 (en) Use of a vitamin D compound and an additional therapeutic agent for the treatment of cancer
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
MX2010005704A (es) Derivados de cromano como modulares del trpv3.
WO2008089093A3 (en) Efficient processes for preparing steroids and vitamin d derivatives with the unnatural configuration at c20 (20 alpha-methyl) from pregnenolone
WO2006066011A3 (en) Compounds and compositions as modulators of steroidal receptors and calcium channel activities
WO2005103010A3 (en) Pyrazole derivatives useful for the treatment of cancer
BRPI0409588A (pt) composto, composição farmacêutica, métodos para ligar seletivamente ao receptor beta de estrogênio em um paciente, para tratar um paciente acometido de uma condição de enfermidade mediada com um receptor beta de estrogênio, para tratar cáncer de próstata e hiperplasia prostática benigna em um paciente, e, uso de um composto
UA104861C2 (uk) Похідні хроману як модулятори trpv3
IL188848A (en) A transient receptor antagonist (TRPVI) i, a pharmaceutical preparation containing it for the treatment of related diseases and conditions.
MXPA05008347A (es) Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis.
WO2007048097A3 (en) Anbrosteeone derivatives and method of use thereof
TW200638932A (en) CCI-779 polymorph and use thereof

Legal Events

Date Code Title Description
NUG Patent has lapsed